LIPOCINE INC. (LPCN) Total liabilities 2016–2025
LIPOCINE INC. (LPCN) total liabilities at each fiscal year-end, per SEC filings.
$2.5MFY2025 · since FY2016: $1.3M → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +67.1% |
| FY2024 | $1.5M | -42.5% |
| FY2023 | $2.6M | +37.9% |
| FY2022 | $1.9M | -72.4% |
| FY2021 | $6.9M | -31.0% |
| FY2020 | $10.0M | -25.1% |
| FY2019 | $13.4M | +17.1% |
| FY2018 | $11.4M | +80.0% |
| FY2017 | $6.3M | +378.5% |
| FY2016 | $1.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LPCN financial trends
LPCN RevenueLPCN Net incomeLPCN Net marginLPCN Gross profitLPCN Gross marginLPCN Operating incomeLPCN Operating marginLPCN Operating cash flowLPCN Free cash flowLPCN Capital expendituresLPCN Return on equityLPCN Stock buybacksLPCN Dividends paidLPCN Total assetsLPCN Shareholders’ equityLPCN overview →